相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Ebola virus disease: An emerging and re-emerging viral threat
Manuel Rojas et al.
JOURNAL OF AUTOIMMUNITY (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Dramatic improvement after tocilizumab of severe COVID-19 in a child with sickle cell disease and acute chest syndrome
Marie-Helene Odievre et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma
Eric Salazar et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
J. -M. Michot et al.
ANNALS OF ONCOLOGY (2020)
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Zhongliang Wang et al.
CLINICAL INFECTIOUS DISEASES (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence
Jeanne Lenzer
BMJ-BRITISH MEDICAL JOURNAL (2020)
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Yan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion
Xinyi Xia et al.
BLOOD (2020)
Use of convalescent plasma in hospitalized patients with COVID-19: case series
Livia Hegerova et al.
BLOOD (2020)
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Yujun Tang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study
Hassan Abolghasemi et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role
Giuseppe Magro
MEDICAL HYPOTHESES (2020)
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
Anup Agarwal et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation
Marina Rieder et al.
CRITICAL CARE (2020)
First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab
Xuhan Zhang et al.
BLOOD ADVANCES (2020)
Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors
Huan Han et al.
EMERGING MICROBES & INFECTIONS (2020)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Immune suppressive properties of artemisinin family drugs
Lifei Hou et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow
O. Garraud et al.
TRANSFUSION CLINIQUE ET BIOLOGIQUE (2016)
Intravenous immunoglobulin in neurology-mode of action and clinical efficacy
Jan D. Luenemann et al.
NATURE REVIEWS NEUROLOGY (2015)
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
John Mair-Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Hyperimmune IV Immunoglobulin Treatment A Multicenter Double-Blind Randomized Controlled Trial for Patients With Severe 2009 Influenza A(H1N1) Infection
Ivan F. N. Hung et al.
CHEST (2013)
Plasma components: properties, differences, and uses
Richard John Benjamin et al.
TRANSFUSION (2012)
Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
Ivan F. N. Hung et al.
CLINICAL INFECTIOUS DISEASES (2011)
West Nile virus neutralization by US plasma-derived immunoglobulin products
Christina B. Planitzer et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
分享论文
